Fda 's Position On Regulation Of Drug Promotion And Advertising

1312 Words6 Pages
FDA 's position on regulation of drug promotion and advertising has undergone a very interesting pathway, and this is clearly reflected in the way they have enacted their regulations. This process has not been spontaneous but rather a result of extemporaneous pressure and events. Initially, as the pharmaceutical industry was growing and rapidly developing, it was also unmonitored, and the claims they made about the products they advertised posed a risk for the consumers given the freedom they had to promote them. For example, the Pure Food and Drug Act was signed in 1906, but it was not stringent enough to prevent the sale of harmful substances: it was directed towards product labeling, and did not have any restrictions about advertising. This evidently created a loophole because it addressed only the topic of misbranding and label content, while false claims that were not included in the label were not prohibited. The tremendous growth experienced by advertising for food, drugs and cosmetics created a demand for the legislation that took place in 1938, the Federal Food, Drug and Cosmetics Act, where FDA was granted greater powers to regulate the industry. This was sharpened by the Sulfanilamide disaster that occurred in 1937: again, "law of action-reaction" manifested, and this is exactly what I find the most interesting, how regulations have been made as a result or response to particular events. More than a preventive strategy, it has always been a reactive one. But

More about Fda 's Position On Regulation Of Drug Promotion And Advertising

Open Document